오리엔트바이오 / 2025.06.19 사업보고서
1. 요약재무정보
가. 요약연결재무정보
(단위 : 원)
구분
제68기
제67기
제66기
[유동자산]
47,414,825,027,000
58,983,945,336,000
49,249,571,579,000
[비유동자산]
37,367,013,662,000
38,003,842,004,000
31,800,648,488,000
자산총계
84,781,838,689,000
96,987,787,340,000
81,050,220,067,000
[유동부채]
4,210,715,028,000
4,206,733,064,000
3,892,299,448,000
[비유동부채]
8,724,327,077,000
7,685,074,591,000
5,765,562,485,000
부채총계
12,935,042,105,000
11,891,807,655,000
9,657,861,933,000
[자본금]
59,291,502,500,000
59,291,502,500,000
59,291,502,500,000
[이익잉여금(결손금)]
2,791,359,814,000
16,107,443,594,000
2,434,890,323,000
자본총계
71,846,796,584,000
85,095,979,685,000
71,392,358,134,000
매출액
29,397,883,042,000
28,005,127,326,000
28,819,028,142,000
영업이익(손실)
(3,076,404,782,000)
(645,945,767,000)
1,452,807,025,000
당기순이익(손실)
(13,194,865,821,000)
12,871,053,378,000
(12,423,707,818,000)
기본주당이익(원)
(111)
109
(105)
희석주당이익(원)
(111)
109
(105)
※ 한국채택국제회계기준 작성기준에 따라 작성되었습니다.